Renaissance Technologies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$2.36M Buy
2023
Q4
$1.36M Buy
2023
Q3
$708K Buy
2023
Q2
$1.02M Buy
2023
Q1
$691K Buy
2022
Q4
$631K Buy
2022
Q3
$1.2M Buy
2022
Q2
$1.21M Buy
2022
Q1
$269K Buy
2021
Q4
Sell
2021
Q3
$538K Sell
2021
Q2
$836K Buy